Slingshot members are tracking this event:

Amgen's (AMGN) AMJEVITA Approved by FDA for Seven Inflammatory Diseases

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 23, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Amjevita, Fda, Inflammatory Diseases, Humira, Moderate-to-severe Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Chronic Plaque Psoriasis, Chron's Disease, Ulcerative Colitis